Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases

Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases

Patients with unresectable hepatic metastases, from uveal or ocular melanoma, are challenging to treat with an overall poor prognosis. Although over the past decade significant advances in systemic therapies have been made, metastatic disease to the liver, especially from uveal melanoma, continues t...

Full description

Bibliographic Details
Main Authors: Michael J. Carr MD, MS, James Sun MD, Jonathan B. Cohen MD, Jinhong Liu MD, Andrew A. Serdiuk DO, Stephen R. Stewart CCP, Navin Doobay CAA, Andrew Duclos CRNA, David A. Seal CRNA, Junsung Choi MD, Jonathan S. Zager MD
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820983019

Internet

https://doi.org/10.1177/1073274820983019

Similar Items